Stay up to date with the latest Synexa news and updates.
About Us
News
Latest updates
Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
Synexa Life Sciences announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.
March 4, 2024
Synexa Life Sciences hosts German Parliamentary Sub-Committee on Global Health at Cape Town laboratories
The visit highlighted the importance of South Africa and Synexa Life Sciences as partners in the CEPI (Coalition for Epidemic Preparedness Innovations) mission to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
February 9, 2024
Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness.
May 30, 2023
Synexa Life Sciences celebrates its 20th anniversary
Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights.
March 3, 2023
Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions
Leading specialist biomarker and bioanalysis solutions provider further strengthens global management team.
August 19, 2022
Synexa Life Sciences expands operations in North America with new Rockville laboratory site
New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases